JONBUR Research · Initiation
DB Insurance · 005830 · Insurance
DB Insurance: Strong Earnings and a 45.2% One-Year Share Gain, With Valuation Above Its Year-End Level
DB Insurance (KOSPI: 005830) closed at ₩193,300 on 2026-10-12, up 45.2% over one year, with a market cap of ₩13.7T. Filed data show trailing net income of ₩1.8T and ROE of 15.7%, while the P/E of 7.5 is higher than the 5.2 recorded at end-2025.
Written Oct 13, 2026 · Data as of Oct 12, 2026 · 0 views
This is not financial advice. The report does not recommend buying or selling anything.
Thesis
The data supports a picture of steady profitability. Operating income was ₩2.2T in 2023, ₩2.4T in 2024 and ₩2.4T in 2025, and the H1 2026 trailing figure is ₩2.6T. Net income was ₩1.7T, ₩1.9T and ₩1.8T over 2023 to 2025, and ₩1.8T on a trailing basis.
The share price has risen 21.5% in three months and 45.2% in one year, and it sits about 9.7% below the 52-week high of ₩214,000. The P/E of 7.5 and P/B of 1.0 are above the year-end 2025 readings of 5.2 and 0.9, so part of the gain reflects a higher multiple rather than earnings alone.
Revenue, margins, investor flows, foreign ownership and short interest are not available in the data, so those aspects cannot be assessed.
Business overview
DB Insurance is an insurer listed on the KOSPI since 1973-06-28 and founded on 1968-11-01. It has 70.8M listed shares and is led by co-CEOs 김정남 and 정종표. At ₩13.7T, its market cap is below Samsung Life Insurance (₩53.5T) and Samsung Fire & Marine Insurance (₩28.6T), but above Hanwha Life (₩4.4T), Hyundai Marine & Fire (₩4.3T) and Mirae Asset Life (₩3.5T). Revenue figures are not available in the data.
Financial analysis
These figures come from filed financial statements (DART). Operating income was ₩2.2T in 2023, ₩2.4T in 2024 and ₩2.4T in 2025. Net income was ₩1.7T, ₩1.9T and ₩1.8T for the same years. ROE was 17.0% in 2023, 19.0% in 2024 and 17.7% in 2025, and is 15.7% on a trailing basis as of H1 2026.
Trailing operating income is ₩2.6T and net income is ₩1.8T. Liabilities to equity stand at 481.2%, a high leverage ratio. Cash is ₩1.2T and trailing free cash flow is ₩5.2T. Revenue, margins and borrowings are not available.
Valuation
The current P/E is 7.5 and P/B is 1.0, versus 5.2 and 0.9 at end-2025. Earlier year-end multiples are not available. The dividend yield is 3.4% and enterprise value is ₩12.5T.
Among peers with data, Samsung Life has a P/E of 19.1 and P/B of 0.4, and Samsung Fire & Marine has a P/E of 13.3 and P/B of 0.8. DB Insurance's P/E is lower than both, while its P/B is higher than both. The other peers lack multiples in the data. P/S and EV/EBITDA are not available.
Catalysts
- The half-year report and preliminary earnings were filed in mid-August 2026, giving the latest trailing figures for operating income, net income and ROE.
- A corporate value-up plan was filed on 2026-08-28, which relates to shareholder return and valuation initiatives, though details are not in the data.
- A change in the largest shareholder's holdings and a 5%+ holding report were filed on 2026-09-22, followed by another 5%+ holding report on 2026-10-02.
- Several related-party transaction filings were made on 2026-09-01, which investors may want to review for scale and counterparties.
Risks
- Leverage is high, with liabilities at 481.2% of equity.
- ROE has eased from 19.0% in 2024 to 15.7% on a trailing basis.
- The P/E has moved up from 5.2 at end-2025 to 7.5, so the share price depends more on earnings holding up.
- The shares rose 21.5% in three months, which leaves them exposed to reversal if sentiment changes.
- Data gaps on revenue, margins, investor flows, foreign ownership and short interest limit the view of demand and positioning.
Closing view
The filed numbers show consistently large profits, double-digit ROE and strong free cash flow, and the shares have risen sharply over the past year. Against that, the multiples are higher than at end-2025, leverage is high and ROE has drifted lower. Without revenue, margin and flow data, the picture is incomplete, and the evidence is best read as mixed-to-positive on profitability and neutral on valuation relative to peers.
Model estimate of fair value
The valuation model has no estimate for this company yet (not enough data, or no positive value with the base case).
Report history
Source: KRX statistical information